Roche and its Genentech subsidiary are planning to hitch up their cardiovascular, renal and metabolism R&D work and shift it over to a new center in Harvard’s Enterprise Research Campus. | Roche and ...

Roche is headquartered in Basel, Switzerland. Swiss pharmaceutical giant Roche operates across a broad spectrum of drug treatment areas, with particular strength in oncology, immunology and neurology.

But works by Basel's native sons, Herzog and de Meuron, are especially ubiquitous. Their two white trapezoidal Roche Towers are ... Unlimited displays large site-specific installations by ...

Our AVENIO assays offer robust solutions for oncology, including the recent approval of the AVENIO Tumor Tissue CGP Automated Kit, a collaboration between Roche and Foundation Medicine, two leaders in ...

Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody in a randomised phase III study to demonstrate a complete renal ...

F. Hoffmann-La Roche Ltd, Building 1, Grenzacherstrasse 124, 4070 Basel, Switzerland. Advances in technology are reshaping healthcare, offering many patients the means to track their own health ...

Columvi plus chemotherapy showed a 41% reduction in the risk of death in the pivotal phase III STARGLO study1,2 DLBCL—an ...

The new center will be a hub for both Roche and Genentech, bringing together expertise in Cardiovascular, Renal, and Metabolism, as well as for data science and AI specialists to drive innovation in d ...